We are looking for a highly motivated PhD candidate with substantial background in stem cell biology and biomedicine, experiences in omics-based approaches ( ...
Cyganek, Lukas, Dr. Group leader at the stem cell unit. Study of chemistry and Biology at Georg-August University, Göttingen; 2009 Staatsexamen (First state ...
Lukas Cyganek is head of the Stem Cell Unit at the University Medical Center Göttingen (http://stemcellunit.de). The SCU offers support within the scope of ...
Our own research focusses on the use of patient-specific and CRISPR-engineered iPSC-cardiomyocytes for disease modelling, tissue engineering, higher-content ...
Group Leader Stem Cell Unit - Cited by 2154 - iPSCs - drug screening - CRISPR gene therapy
Lukas Cyganek
Researcher
>
Research interests: iPSCs, Drug Screening, and CRISPR gene therapy
Works (50 of 66) · Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants · Atrial fibrillation-associated ...
Lukas Cyganek · PhD | Head ' Stem Cell Unit ' University Medical Center Göttingen | Group Leader ' Fraunhofer ITMP · Gemeinsame Kontakte mit Lukas Cyganek ...
Lukas Cyganek, Doctorate, Senior Researcher, University Medical Center Göttingen, Göttingen, Germany.
Dr. rer. nat. Lukas Cyganek, Group leader, Phone: +49 (0) 551 / 39 64280, Mail: lukas.cyganek@gwdg.de, Office: UMG 0.D2 604 / Lab
Exploring hypertrophic cardiomyopathy in iPSC-derived cardiomyocytes from patients with a novel autosomal recessive form of Noonan syndrome.